NBS1 (Nijmegen Breakage Syndrome 1), also known as nibrin, is a key protein in the DNA damage response (DDR) machinery. As part of the MRN complex (MRE11-RAD50-NBS1), NBS1 senses DNA double-strand breaks (DSBs), activates ATM kinase signaling, and facilitates DNA repair. Given the high metabolic activity and post-mitotic nature of neurons, proper DNA repair is critical for neuronal survival, making NBS1 relevant to neurodegenerative disease research[1][2].
NBS1 is a 754-amino acid protein encoded by the NBN gene (formerly NBS1). It contains multiple functional domains: [1]
NBS1 functions as part of the MRN complex, which: [2]
Neurons are highly metabolic cells with long life spans, requiring robust DNA repair mechanisms to maintain genomic integrity. The MRN complex is essential for repairing DNA damage from oxidative stress, a constant challenge in the brain. NBS1 deficiency leads to accumulation of DNA damage in neurons and progressive neurodegeneration.
Following DNA damage, NBS1 recruits and activates ATM kinase, which phosphorylates downstream targets including p53, H2AX, and checkpoint kinases. This cascade leads to cell cycle arrest, DNA repair, or apoptosis. Defective ATM-NBS1 signaling contributes to neuronal death in various conditions.
Emerging evidence suggests NBS1 has functions at synapses, where it may participate in DNA repair within neuronal processes and contribute to synaptic plasticity.
This autosomal recessive disorder caused by NBS1 mutations features:
Patients show impaired DNA repair and increased sensitivity to ionizing radiation[2].
NBS1 and the MRN complex are dysregulated in Alzheimer's disease brains. DNA damage accumulates in AD neurons, and impaired NBS1 function may contribute to this process. The protein interacts with amyloid-beta and tau pathology in complex ways.
DNA damage accumulates in dopaminergic neurons in PD. NBS1-mediated DNA repair pathways may be compromised, contributing to neuronal vulnerability. Studies show altered NBS1 expression in PD models.
Some NBS1 mutations cause ATLD (ataxia-telangiectasia-like disease), a condition with overlapping features including cerebellar ataxia and increased cancer risk.
Modulating NBS1 function and the broader DNA damage response represents a therapeutic strategy for neurodegenerative diseases. Approaches include:
However, given NBS1's role in cancer suppression, careful balancing is required[3].
Chrzanowska et al. Nijmegen breakage syndrome (2012). 2012. ↩︎
Madabhushi et al. DNA damage and neurodegeneration (2014). 2014. ↩︎